Evidence map›Paper›PMID 30737479›Full record

ArticleEuropean journal of human genetics : EJHG2019

Segmental and total uniparental isodisomy (UPiD) as a disease mechanism in autosomal recessive lysosomal disorders: evidence from SNP arrays.

Ineke Labrijn-Marks, Galhana M Somers-Bolman, Stijn L M In 't Groen, Marianne Hoogeveen-Westerveld, Marian A Kroos, Sirpa Ala-Mello, Olga Amaral, Clara Sa Miranda, Irene Mavridou, Helen Michelakakis and 10 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. NovelMolecular therapy. Methods & clinical development · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 5 countries.

Ineke Labrijn-MarksDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Galhana M Somers-BolmanDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Stijn L M In 't GroenMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marianne Hoogeveen-WesterveldDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marian A KroosDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Sirpa Ala-MelloDepartment of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
Olga AmaralDepartment of Human Genetics, Unit of Research and Development, National Institute of Health Dr Ricardo Jorge, Porto, Portugal.
Clara Sa MirandaUnilipe, IBMC-University of Porto, Porto, Portugal.
Irene MavridouDepartment of Enzymology and Cellular Function, Institute of Child Health, Athens, Greece.
Helen MichelakakisDepartment of Enzymology and Cellular Function, Institute of Child Health, Athens, Greece.
Karin NaessCentre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.
Frans W VerheijenDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Lies H HoefslootDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Trijnie DijkhuizenDepartment of Genetics, University Medical Center Groningen (UMCG), Groningen, the Netherlands.
Marloes BenjaminsDepartment of Genetics, University Medical Center Groningen (UMCG), Groningen, the Netherlands.
Hannerieke J M van den HoutDepartment of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus University Medical Center-Sophia, Rotterdam, The Netherlands.
Ans T van der PloegDepartment of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus University Medical Center-Sophia, Rotterdam, The Netherlands.
W W M Pim PijnappelMolecular Stem Cell Biology, Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jasper J SarisDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9232-267X
Dicky J HalleyDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. d.halley@erasmusmc.nl.
Erasmus MC · NLInstitute of Child Health · GRUniversity Medical Center Groningen · NLKarolinska University Hospital · SENational Institute of Health Dr. Ricardo Jorge · PTUniversidade do Porto · PTUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analyses in our diagnostic DNA laboratory include genes involved in autosomal recessive (AR) lysosomal storage disorders such as glycogenosis type II (Pompe disease) and mucopolysaccharidosis type I (MPSI, Hurler disease). We encountered 4 cases with apparent homozygosity for a disease-causing sequence variant that could be traced to one parent only. In addition, in a young child with cardiomyopathy, in the absence of other symptoms, a diagnosis of Pompe disease was considered. Remarkably, he presented with different enzymatic and genotypic features between leukocytes and skin fibroblasts. All cases were examined with microsatellite markers and SNP genotyping arrays. We identified one case of total uniparental disomy (UPD) of chromosome 17 leading to Pompe disease and three cases of segmental uniparental isodisomy (UPiD) causing Hurler-(4p) or Pompe disease (17q). One Pompe patient with unusual combinations of features was shown to have a mosaic segmental UPiD of chromosome 17q. The chromosome 17 UPD cases amount to 11% of our diagnostic cohort of homozygous Pompe patients (plus one case of pseudoheterozygosity) where segregation analysis was possible. We conclude that inclusion of parental DNA is mandatory for reliable DNA diagnostics. Mild or unusual phenotypes of AR diseases should alert physicians to the possibility of mosaic segmental UPiD. SNP genotyping arrays are used in diagnostic workup of patients with developmental delay. Our results show that even small Regions of Homozygosity that include telomeric areas are worth reporting, regardless of the imprinting status of the chromosome, as they might indicate segmental UPiD.

Indexed as

Polymorphism, Single NucleotideUniparental DisomyAdolescentChildChild, PreschoolFemaleGlycogen Storage Disease Type IIHumansInfantMaleMucopolysaccharidosis I

Identifiers

PMID30737479
PMCPMC6777471
OpenAlexW2914241872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.